Economic impact of rheumatoid arthritis (RA) biotherapies in France.

@article{Maravic2010EconomicIO,
  title={Economic impact of rheumatoid arthritis (RA) biotherapies in France.},
  author={Milka Maravic},
  journal={Joint, bone, spine : revue du rhumatisme},
  year={2010},
  volume={77 4},
  pages={
          319-24
        }
}
OBJECTIVE Determining the economic impact of rheumatoid arthritis (RA) biotherapies in France. METHOD The number of patients on RA biotherapy in France was estimated from the French national medical information system program (PMSI) database using the 2007 hospital data. The cost of each biotherapy was calculated on a theoretical basis (French national health authority (HAS) recommendations) and on real-life setting, using 'real-life' setting data. In order to calculate the economic impact of… CONTINUE READING